메뉴 건너뛰기
Journal of Rheumatology
Volumn 33, Issue 4, 2006, Pages 642-643
What are open-label extension studies for?
Author keywords

[No Author keywords available]
Indexed keywords

ETANERCEPT; PREDNISOLONE;
EID: 33645800198     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (13)
References (7)
  • 1
    • 33645804643 scopus 로고    scopus 로고
    • Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept
    • Mease PJ, Kivitz AJ, Burch FX, et al. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. J Rheumatol 2006;33:712-21.
    • (2006) J Rheumatol , vol.33 , pp. 712-721
    • Mease, P.J.1    Kivitz, A.J.2    Burch, F.X.3
  • 2
    • 0000957197 scopus 로고
    • Report by the Joint Committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone ACTH, and other therapeutic measures in chronic rheumatic diseases. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis
    • Report by the Joint Committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone ACTH, and other therapeutic measures in chronic rheumatic diseases. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959;18:173-88.
    • (1959) Ann Rheum Dis , vol.18 , pp. 173-188
  • 3
    • 23644459274 scopus 로고    scopus 로고
    • Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
    • Davis JC, van der Heijde DM, Braun J, et al. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks. Ann Rheum Dis 2005;64:1557-62.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1557-1562
    • Davis, J.C.1    Van Der Heijde, D.M.2    Braun, J.3
  • 4
    • 0035857966 scopus 로고    scopus 로고
    • The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials
    • Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
    • (2001) Lancet , vol.357 , pp. 1191-1194
    • Moher, D.1    Schulz, K.F.2    Altman, D.G.3
  • 5
    • 0032900520 scopus 로고    scopus 로고
    • Reporting requirements for longitudinal observational studies in rheumatology
    • Silman A, Symmons D. Reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1999;26:481-3.
    • (1999) J Rheumatol , vol.26 , pp. 481-483
    • Silman, A.1    Symmons, D.2
  • 6
    • 0032948151 scopus 로고    scopus 로고
    • Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology
    • Wolfe F, Lassere M, van der Heijde D, et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1999;26:484-9.
    • (1999) J Rheumatol , vol.26 , pp. 484-489
    • Wolfe, F.1    Lassere, M.2    Van Der Heijde, D.3
  • 7
    • 24644446896 scopus 로고    scopus 로고
    • Open label extension studies: Research or marketing?
    • Taylor GJ, Wainwright P. Open label extension studies: research or marketing? BMJ 2005;331:572-4.
    • (2005) BMJ , vol.331 , pp. 572-574
    • Taylor, G.J.1    Wainwright, P.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.